Trial intelligence / Profile preview

Adsorbed Tetanus Vaccine in Healthy Adults 18-43

CTR20234300Phase 3Completed

Sponsor
Beijing Minhai Biological
Start
Dec 2023
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Tetanus Vaccine (Adsorbed) in Tetanus, sponsored by Beijing Minhai Biological. Started Dec 2023; status: completed.

02

Drugs

Tetanus Vaccine (Adsorbed)
03

Conditions

Tetanus

Beyond the preview

Go deeper on CTR20234300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20234300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call